Drug Trial Radar · NCT07004972
A Study of Mavacamten in Adults With Obstructive Hypertrophic Cardiomyopathy in India (ROVER)
Last checked: Nov 20, 2026Latest source record: Apr 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
50
Planned (sponsor's estimate)
Start
Sep 4, 2025
Primary completion
Dec 13, 2027
Study completion Dec 13, 2027
Sponsor
- Lead sponsor
- Bristol-Myers SquibbBristol Myers Squibb (BMY)
- Sponsor type
- Industry
- First posted
- Jun 4, 2025
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety, tolerability and effectiveness of mavacamten in adults with obstructive hypertrophic cardiomyopathy in India.
Conditions
- Symptomatic Obstructive Hypertrophic Cardiomyopathy
Interventions
MavacamtenDrug
Specified dose on specified days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of serious Treatment Emergent Adverse Events (TEAEs)Time frame: Up to Week 48
Locations
24 sites in 1 country. Site status is shown where the registry gives one.
Local Institution - 0014
Hyderabad, Andhra Pradesh, India
Local Institution - 0011
Ahmedabad, Gujarat, India
Local Institution - 0006
Surat, Gujarat, India
Local Institution - 0020
Gurgaon, Haryana, India
Medanta Heart Institute
Gurgaon, Haryana, India
Local Institution - 0004
Belagavi, Karnataka, India
Local Institution - 0008
Mangalore, Karnataka, India
Local Institution - 0002
Ernākulam, Kerala, India
Local Institution - 0001
Kottayam, Kerala, India
Local Institution - 0012
Chhatrapati Sambhajinagar, Maharashtra, India
Local Institution - 0025
Mumbai, Maharashtra, India
Local Institution - 0025
Mumbai, Maharashtra, India
Local Institution - 0013
Nagpur, Maharashtra, India
Local Institution - 0019
Nagpur, Maharashtra, India
Local Institution - 0024
Nagpur, Maharashtra, India
Local Institution - 0010
Pune, Maharashtra, India
Local Institution - 0021
New Delhi, National Capital Territory of Delhi, India
Local Institution - 0005
New Delhi, National Capital Territory of Delhi, India
Local Institution - 0007
Bikaner, Rajasthan, India
Local Institution - 0003
Chennai, Tamil Nadu, India
Local Institution - 0022
Aligarh, Uttar Pradesh, India
Laxmipat Singhania Institute of Cardiology
Kanpur, Uttar Pradesh, India
Local Institution - 0023
Kanpur, Uttar Pradesh, India
Local Institution - 0017
Kolkata, West Bengal, India
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.